On September 11, 2023, Comera Life Sciences Holdings, Inc. closed the transaction. The company issued 3,561,851 common shares and warrants to purchase up to an additional 8,904,641 shares for the gross proceeds of $1.82 million in its final tranche.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0292 USD | -4.72% | +9.33% | -46.73% |
01-30 | Comera Life Sciences Holdings, Inc. Announces Chief Executive Officer Changes | CI |
01-30 | Comera Life Sciences Holdings, Inc. Announces Changes to Its Board | CI |
1st Jan change | Capi. | |
---|---|---|
-46.73% | 944K | |
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |
- Stock Market
- Equities
- CMRA Stock
- News Comera Life Sciences Holdings, Inc.
- Comera Life Sciences Holdings, Inc. announced that it has received $4.069993 million in funding